Jamey Marth
| Jamey Marth | |
|---|---|
| Alma mater | University of Washington |
| Scientific career | |
| Fields |
Molecular biology Cellular biology |
| Institutions |
SBP Medical Discovery Institute UC Santa Barbara Howard Hughes Medical Institute UC San Diego |
Jamey Marth, Ph.D., is a molecular and cellular biologist. He is currently on the faculty of the University of California, Santa Barbara (UCSB) and the SBP Medical Discovery Institute of La Jolla, California and Lake Nona, Orlando. At UCSB, Dr. Marth is the Director of the Center for Nanomedicine and a Professor in the Department of Molecular, Cellular and Developmental Biology. He is also the inaugural recipient of the John Carbon Endowed Chair of Biochemistry and Molecular Biology and the recipient of the Duncan and Suzanne Mellichamp Endowed Chair of Systems Biology.
His research has largely focused on molecular cell biology and, in particular, how protein glycosylation contributes to the mechanisms of health and common diseases including diabetes, sepsis, inflammatory diseases, and autoimmunity. His research has demonstrated metabolic causes of common diseases that do not originate from genetic mutation and variation, and is credited with the conception and co-development of Cre-Lox recombination as a form of conditional mutagenesis in living mammals.
Marth earned a Ph.D. in Pharmacology from the University of Washington in 1987. During his time at Washington as a graduate student, he was mentored by Roger M. Perlmutter and Edwin G. Krebs. Marth was Perlmutter's first graduate student. Marth's first faculty position after earning his doctorate was at the University of British Columbia's Biomedical Research Centre in Vancouver, British Columbia, Canada.
...
Wikipedia